Cryptococcus neoformans and cryptococcosis.
Harrison
T S
TS
Department of Infectious Diseases, St. George's Hospital Medical School, London, U.K.
D000908:Antibodies, Fungal / Q000096:biosynthesis; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D003453:Cryptococcosis / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology* / Q000628:therapy; D003455:Cryptococcus neoformans / Q000276:immunology / Q000472:pathogenicity / Q000502:physiology*; D016207:Cytokines / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular; D008264:Macrophages / Q000276:immunology; D014774:Virulence
D000908:Antibodies, Fungal; D000911:Antibodies, Monoclonal; D000935:Antifungal Agents; D016207:Cytokines